Hyderabad, Sept. 28: India has secured exemptions from US tariffs on several categories of specialty pharmaceutical products and ingredients, offering targeted relief to Indian drug manufacturers.
The US Commerce Department included India among countries eligible for zero tariffs on specified pharmaceutical products. The exemption comes as Washington prepares to impose 100 per cent tariffs on certain patented pharmaceutical imports and their associated ingredients from September 29.
US Tariff Exemption Covers Specialty Medicines
The exemption applies to selected products covered by a presidential proclamation issued in April. Eligible categories include orphan drugs, nuclear medicines, plasma-derived therapies, fertility drugs, cell therapies, gene therapies and antibody-drug conjugates.
The list also includes medical countermeasures for chemical, biological, radiological and nuclear threats, along with certain animal health products.
India features alongside several other countries and trading blocs eligible for the exemptions. These include Japan, South Korea, Britain, the European Union, Bangladesh, Indonesia, Malaysia, Thailand and Vietnam.
Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe. Click to follow Indtoday’s Facebook page, Twitter, and Instagram. For all the latest Hyderabad News updates and Follow us on GoogleNews
